Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Panarum Logo
Panarum Growth Score
38
CB Rank
71736
Heat Score
73
Panarum manufactures and commercializes Proteoral excipient for oral proteins, replacing injections.
Founded
obfuscation
PrivateGrant Newark, Delaware, United States1-10 panarum.com/
Biotechnology
Health Care
Medical
Pharmaceutical
Overview

Panarum
Total Funding
obfuscation
Growth Score
38
Heat Score
73

Total Funding
obfuscation
Grant raised
obfuscation
Growth Score38
-4 pts
in past quarter
Heat Score 73
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Panarum

CB Rank
71736
Panarum manufactures and commercializes Proteoral excipient for oral proteins, replacing injections.
Founded
obfuscation
PrivateGrant Newark, Delaware, United States1-10 panarum.com/
Biotechnology
Health Care
Medical
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation
Pre-Seed
OBF
in
obfuscation
Pre-Seed
OBF
in
obfuscation

Key People

Details

Legal Name Panarum SAS
Also Known As Proteoral
Operating Status Active
Company Type For Profit
Founders  Milena Batalla
About the Company
Panarum manufactures and commercializes Proteoral excipient for oral proteins, replacing injections.
Phone Number +54 9 1168206962
Contact Email universe@panarum.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Proteoral
Proteoral is a recombinant protein excipient that facilitates the oral delivery of biological active pharmaceutical ingredients by opening intestinal epithelial junctions for absorption.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Panarum Logo
Grant - Panarum
1
obfuscation
Johnson & Johnson FoundationGrant
obfuscation
Grant - Panarum Logo
Grant - Panarum
1
obfuscation
Johnson & Johnson FoundationGrant
obfuscation
Grant - Panarum Logo
Grant - Panarum
1
obfuscation
Johnson & Johnson FoundationGrant
obfuscation
Grant - Panarum Logo
Grant - Panarum
1
obfuscation
Johnson & Johnson FoundationGrant
obfuscation
Grant - Panarum Logo
Grant - Panarum
1
obfuscation
Johnson & Johnson FoundationGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Panarum Logo
Grant - Panarum
1
obfuscation
Johnson & Johnson FoundationGrant
obfuscation
Grant - Panarum Logo
Grant - Panarum
1
obfuscation
Johnson & Johnson FoundationGrant
obfuscation
Grant - Panarum Logo
Grant - Panarum
1
obfuscation
Johnson & Johnson FoundationGrant
obfuscation
Grant - Panarum Logo
Grant - Panarum
1
obfuscation
Johnson & Johnson FoundationGrant
obfuscation
Grant - Panarum Logo
Grant - Panarum
1
obfuscation
Johnson & Johnson FoundationGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Johnson & Johnson Foundation Logo
Johnson & Johnson Foundation
Yes
Grant - Panarum Logo
Grant - Panarum
—
Johnson & Johnson Foundation Logo
Johnson & Johnson Foundation
Yes
Grant - Panarum Logo
Grant - Panarum
—
Johnson & Johnson Foundation Logo
Johnson & Johnson Foundation
Yes
Grant - Panarum Logo
Grant - Panarum
—
Johnson & Johnson Foundation Logo
Johnson & Johnson Foundation
Yes
Grant - Panarum Logo
Grant - Panarum
—
Johnson & Johnson Foundation Logo
Johnson & Johnson Foundation
Yes
Grant - Panarum Logo
Grant - Panarum
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

126
-50.97%
 in past month

Active Website Tech Count

18Panarum is actively using 18 technologies for its website, according to BuiltWith. These include SPF, Google Font API, and  Apple Mobile Web Clips Icon.
Sub-Organizations
Frequently Asked Questions

Where is Panarum's headquarters? Panarum is located in Newark, Delaware, United States.Who invested in Panarum? Panarum has 3 investors including Johnson & Johnson Foundation and  Draper Startup House Ventures.When was the last funding round for Panarum? Panarum closed its last funding round on
obfuscation
from a Grant round.Who are Panarum's competitors? Alternatives and possible competitors to Panarum may include Rani Therapeutics, Novo Nordisk, and  Lyndra Therapeutics.How much funding has Panarum raised to date? Panarum has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(bc80b4a 1)
|